Novel chocolate composition as delivery system for nutrients and medications

Abstract

A novel chocolate product for use in delivering medicaments and / or nutrients to animals, particularly humans, specially formulated so that the craving for such product by animals, particularly humans, is significantly greater than the craving for chocolate conventionally used in pharmaceutical compositions and the concentration, optimization, and the addition of endogenous and exogenous ingredients to increase such craving as well as to treat specific indications. The chocolate product contains: from about 0.5 to about 200 milligrams, more preferably from about 5 to about 20 milligrams, of one or more biogenic amines per 1 gram of the chocolate product; from about 10 to about 500 milligrams, more preferably form about 20 to about 200 milligrams, of one or more amino acids per 1 gram of the chocolate product; (C) from about 1 microgram to about 20 milligrams, more preferably from about 10 micrograms to about 10 milligrams, of one or more of: methyl tetrahydroisoquinoline, N-acylethanolamines, and / or anandamide and / or salsolinol per 1 gram of the chocolate product; (D) from about 0.2 to about 30 milligrams of at least one trace mineral per 1 gram of the chocolate product; and (E) from 0.6 to about 500 milligrams, more preferably from about 35 to about 100 milligrams, of one or more methylxanthine alkaloids per 1 gram of the chocolate product. The chocolate product used in this invention also preferably contains effective amounts of at least one chocolate aroma and at least one vanilla aroma.

Description

CROSS-REFERENCE TO RELATED DOCUMENTS [0001] The present non-provisional patent application claims priority to provisional application Ser. No. 60 / 279,715, which is incorporated herein in its entirety by reference.FIELD OF THE INVENTION [0002] The present invention is in the field of carriers for administering nutrient and / or medicant compositions to animals, particularly to humans, and pertains more particularly to the preparation of such carriers to enhance the probability of consistent use by the animals for which the carrier is intended. BACKGROUND OF THE INVENTION [0003] This invention relates to carriers for use in nutrient- and / or medicament-containing compositions designed to treat various ailments health conditions that commonly occur in mammals. More particularly, this invention relates to a novel chocolate composition as a delivery system for nutrients and medications wherein the composition is formulated to increase a patient's desire to consume the nutrients and medicati...

AI Technical Summary

Benefits of technology

[0051] The present invention is based in part on the discovery that for a chocolate-containing delivery system or carrier to have more than just the normal craving casually associated with chocolate or a simple placebo effect, or, not to counteract the intended treatment, the ingredients responsible for the physiological cravings must be present in at least minimum amounts and in the correct proportions. If a delivery system does not contain sufficient amounts or ratios of the ingredients responsible for the physiological craving for chocolate, the chocolate will counteract the benefits of the nutritional or medical delivery system and possibly worsen the specific indications intended to be treated.

[0068] In addition to endogenous craving-enhancing ingredients (A)-(E), the chocolate product of this invention may further contain one or more exogenously added ingredients which synergistically act with ingredients (A)-(E) to increase the craving properties of the chocolate product composition and / or the efficacy of the chocolate product to treat specific indications. The exogenously added ingredient(s) is preferably selected from the group consisting of dong quai, damiana, jaborandi, capsicum, echinacea, astragalus, evening primrose, feverfew, garlic, ginger, ginkgo, ginseng (panax and siberian), goldenseal, green tea, hawthorn, horse chestnut, kava, licorice, milk thistle, reishi, saw palmetto, St. John's Wort, valerian, vitex, murapuama, catuaba, clavo huasca, sangre de drago, jatoba, yerba mate, acerola, amor seco, avena sativa, boldo, maca, kola nut, bitter orange extract, Garcinia cambogia, ephedrine, chromium, 5-HTP, yohimbe, nettle, bilbeny, rhodiola, gotu kola, and suma.

Problems solved by technology

If a delivery system does not contain sufficient amounts or ratios of the ingredients responsible for the physiological craving for chocolate, the chocolate will counteract the benefits of the nutritional or medical delivery system and possibly worsen the specific indications intended to be treated.